The accompanying notes
are an integral part of these unaudited condensed financial statements.
The accompanying notes
are an integral part of these unaudited condensed financial statements.
The accompanying notes
are an integral part of these unaudited condensed financial statements.
The accompanying notes
are an integral part of these unaudited condensed financial statements.
NOTES TO CONDENSED
UNAUDITED FINANCIAL STATEMENTS
SEPTEMBER 30, 2021
Note 1 — Organization
and Business Operations
Agrico Acquisition
Corp. (the “Company”) was incorporated as a Cayman Islands exempted company on July 31, 2020. The Company was incorporated
for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination
with one or more businesses (the “Business Combination”).
As of September
30, 2021, the Company had not commenced any operations. All activity through September 30, 2021 relates to the Company’s formation
and preparation for the Initial Public Offering (the “Public Offering” or “IPO”) as described below, and
subsequent to the IPO, identifying a target company for a Business Combination. The Company will
not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company generates non-operating income
in the form of interest income and unrealized gains from the cash and marketable securities held in the Trust Account. The
Company has selected December 31 as its fiscal year end.
The Company’s
sponsor is DJCAAC, LLC, a Delaware limited partnership (the “Sponsor”). The registration statement for the Company’s
IPO was declared effective on July 7, 2021 (the “Effective Date”). On July 12, 2021, the Company consummated the initial public
offering (the “Public Offering” or “IPO”) of 14,375,000 units (the “Units”), which includes
the full exercise by the underwriters of the over-allotment option to purchase an additional 1,875,000 Units, at $10.00 per
unit, generating gross proceeds of $143,750,000, which is discussed in Note 4. Simultaneously with the closing of the IPO, the Company
consummated the sale of 7,250,000 warrants to the Sponsor and Maxim Group LLC (“Maxim”), the underwriter in this
offering (the “Private Placement Warrants”), at a price of $1.00 per Private Placement Warrant, generating gross proceeds
of $7,250,000, which is discussed in Note 5. Each Private Placement Warrant is exercisable to purchase one Class A ordinary
share at $11.50 per share.
Transaction
costs of the IPO amounted to $9,998,781, comprised of $2,875,000 of underwriting fees paid at the time of the IPO, $5,031,250 of
deferred underwriting fees, $655,031 of other offering costs, and $1,437,500 of the fair value of the representative shares,
and was all charged to shareholders’ equity.
Following
the closing of the IPO on July 12, 2021, $146,625,000 (approximately $10.20 per Unit) from the net proceeds of the sale of the
Units in the IPO, including a portion of the proceeds from the sale of the Private Placement Warrants, was deposited in a trust account
(“Trust Account”), located in the United States with Continental Stock Transfer & Trust Company acting as trustee,
and may only be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company
Act, having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated
under the Investment Company Act which invest only in direct U.S. government treasury obligations. Except with respect to interest earned
on the funds held in the Trust Account that may be released to the Company to pay taxes, if any, the proceeds from the IPO and the sale
of the Private Placement Warrants will not be released from the Trust Account (1) to the Company, until the completion of the initial
Business Combination, or (2) to the public shareholders, until the earliest of (a) the completion of the initial Business Combination,
and then only in connection with those Class A ordinary shares that such shareholders properly elected to redeem, subject to the
limitations, (b) the redemption of any public shares properly tendered in connection with a (A) shareholder vote to amend the
amended and restated memorandum and articles of association to modify the substance or timing of the Company’s obligation to provide
holders of the Class A ordinary shares the right to have their shares redeemed in connection with the initial Business Combination
or to redeem 100% of the public shares if the Company does not complete the initial Business Combination within 24 months from the
closing of the Initial public offering (the “Combination Period”), or (B) with respect to any other provision relating
to the rights of holders of the Class A ordinary shares or pre-initial business combination activity, and (c) the
redemption of the public shares if the Company has not consummated the initial Business Combination within 24 months from the closing
of the Initial public offering. Public shareholders who redeem their Class A ordinary shares in connection with a shareholder vote
described in clause (b) in the preceding sentence shall not be entitled to funds from the Trust Account upon the subsequent completion
of an initial Business Combination or liquidation if the Company has not consummated an initial Business Combination within the Combination
Period, with respect to such Class A ordinary shares so redeemed. The proceeds deposited in the Trust Account could become subject
to the claims of the Company’s creditors, if any, which could have priority over the claims of the public shareholders.
The Company
will provide its public shareholders with the opportunity to redeem all or a portion of their public shares upon the completion of the
initial Business Combination either (i) in connection with a general meeting called to approve the initial Business Combination or
(ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a proposed initial Business
Combination or conduct a tender offer will be made by the Company, solely in its discretion. The shareholders will be entitled to redeem
their shares for a pro rata portion of the amount then on deposit in the Trust Account (initially approximately $10.20 per share, plus
any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations).
If the Company
is unable to complete a Business Combination within 12 months (or up to 21 months if the Company extends the period of time to consummate
a business combination by the full amount of time) from the closing of the Public Offering (the “Combination Period”) or during
any Extension Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably
possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the
aggregate amount then on deposit in the trust account including interest earned on the funds held in the trust account and not previously
released to us to pay the Company’s franchise and income taxes (less up to $50,000 of interest to pay dissolution expenses), divided
by the number of then outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders
(including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably
possible following such redemption, subject to the approval of the Company’s remaining shareholders and board of directors, liquidate
and dissolve, subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and
the requirements of other applicable law.
The Sponsor,
officers and directors have agreed to (i) waive their redemption rights with respect to their Founder Shares and Public Shares in
connection with the completion of the initial Business Combination, (ii) waive their redemption rights with respect to their Founder
Shares and Public Shares in connection with a shareholder vote to approve an amendment to the Company’s amended and restated certificate
memorandum and articles of association (A) that would modify the substance or timing of the Company’s obligation to redeem 100%
of the its Public Shares if the Company does not complete its initial Business Combination within the Combination Period or (B) with
respect to any other provision relating to shareholders’ rights or pre-initial Business Combination activity, (iii) waive their
rights to liquidating distributions from the Trust Account with respect to their Founder Shares if the Company fails to complete an initial
Business Combination within the Combination Period, although they will be entitled to liquidating distributions from the Trust Account
with respect to any Public Shares they hold if the Company fails to complete the initial Business Combination within the prescribed timeframe,
and (iv) vote their Founder Shares and Public Shares in favor of the Company’s initial Business Combination.
The Sponsor
has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold
to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or
similar agreement or business combination agreement, reduce the amount of funds in the trust account to below the lesser of (i) $10.00 per
public share and (ii) the actual amount per public share held in the trust account as of the date of the liquidation of the trust
account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such
liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to
the monies held in the trust account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s
indemnity of the underwriter of the Public Offering against certain liabilities, including liabilities under the Securities Act. However,
the Company has not asked its Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether
its Sponsor has sufficient funds to satisfy its indemnity obligations and believes that the Company’s Sponsor’s only assets
are securities of the Company. Therefore, the Company cannot assure that its Sponsor would be able to satisfy those obligations.
Liquidity
and Capital Resources
As of September
30, 2021 the Company had $959,953 in cash and a working capital of $722,520. The Company’s liquidity needs up to September
30, 2021 had been satisfied through a capital contribution from the Sponsor of $25,000 (see Note 6) for the founder shares and the
loan under an unsecured promissory note from the Sponsor of up to $300,000 (see Note 6). In addition, in order to finance transaction
costs in connection with a Business Combination, the Company’s Sponsor or an affiliate of the Sponsor or certain of the Company’s
officers and directors may, but are not obligated to, provide the Company Working Capital Loans (see Note 6). As of September 30, 2021
and December 31, 2020, there were no amounts outstanding under any Working Capital Loans.
Based on
the foregoing, management believes that the Company will have sufficient working capital and borrowing capacity to meet its needs through
the earlier of the consummation of a Business Combination or one year from this filing. Over this time period, the Company will be using
these funds for paying existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing
due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire,
and structuring, negotiating and consummating the Business Combination.
Risks
and Uncertainties
Management
continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus
could have a negative effect on the Company’s financial position, results of its operations, and/or search for a target company,
the specific impact is not readily determinable as of the date of these unaudited condensed financial statements. The unaudited condensed
financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Note
2 — Restatement of Previously Issued Financial Statements
In connection with the
preparation of the Company’s financial statements as of September 30, 2021, management determined it should restate its previously
reported audited balance sheet included on Form 8-K . The Company previously determined the ordinary share subject to possible redemption
to be equal to the redemption value of $10.20 per ordinary share while also taking into consideration its charter’s requirement
that a redemption cannot result in net tangible assets being less than $5,000,001. Upon review of its financial statements for the period
ended September 30, 2021, the Company reevaluated the classification of the ordinary shares and determined that the ordinary shares issued
during the Initial Public Offering and pursuant to the exercise of the underwriters’ overallotment can be redeemed or become redeemable
subject to the occurrence of future events considered outside the Company’s control under ASC 480-10-S99. Therefore, management
concluded that the carrying value should include all ordinary shares subject to possible redemption, resulting in the ordinary shares subject
to possible redemption being classified as temporary equity in its entirety. As a result, management has noted a reclassification adjustment
related to temporary equity and permanent equity. This resulted in an adjustment to the initial carrying value of the ordinary shares subject
to possible redemption with the offset recorded to additional paid-in capital (to the extent available), retained earnings (accumulated
deficit) and ordinary shares.
There has been no change
in the Company’s reported total assets, liabilities or operating results.
The impact of the restatement
on the Company’s financial statement is reflected in the following table:
|
|
As
Reported
|
|
|
Adjustment
|
|
|
As
Restated
|
|
Balance Sheet as of July 12, 2021 (as per form 8K filed on July 21, 2021)
|
Class A Ordinary share subject to possible redemption
|
|
$
|
137,448,733
|
|
|
$
|
9,176,267
|
|
|
$
|
146,625,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class A Ordinary shares, $0.0001 par value
|
|
|
104
|
|
|
|
(90
|
)
|
|
|
14
|
|
Additional Paid in Capital
|
|
|
5,014,523
|
|
|
|
(5,014,523
|
)
|
|
|
-
|
|
Accumulated Deficit
|
|
|
(14,977
|
)
|
|
|
(4,161,654
|
)
|
|
|
(4,176,631
|
)
|
Total Stockholders’ Equity (Deficit)
|
|
$
|
5,000,009
|
|
|
$
|
(9,176,267
|
)
|
|
$
|
(4,176,258
|
)
|
Number of Class A Ordinary shares
subject to redemption
|
|
|
13,475,366
|
|
|
|
899,634
|
|
|
|
14,375,000
|
|
Note
3 — Significant Accounting Policies
Basis
of Presentation
The accompanying
unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United
States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and
Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements
prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial
reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position,
results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include
all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating
results and cash flows for the periods presented.
The accompanying
unaudited condensed financial statements should be read in conjunction with the Company’s Prospectus which contains the initial
audited financial statements and notes thereto for the period from July 31, 2020 (inception) to December 31, 2020 as filed with the SEC
on July 12, 2021. The interim results for the three and nine months ended September 30, 2021 and are not necessarily indicative of the
results to be expected for the year ending December 31, 2021 or for any future interim periods.
Emerging
Growth Company Status
The Company
is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart our Business
Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements
that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required
to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding
executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory
vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.
Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting
standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not
have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards.
The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply
to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of
such extended transition period which means that when a standard is issued or revised and it has different application dates for public
or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies
adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which
is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult
or impossible because of the potential differences in accounting standards used.
Use of
Estimates
The preparation
of the financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement and the reported
amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgement. It is at least
reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the
financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future
confirming events. Accordingly, the actual results could differ significantly from those estimates.
Cash
and Cash Equivalents
The Company
considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company
did not have any cash equivalents as of September 30, 2021 or December 31, 2020.
Marketable Securities Held in Trust Account
At September 30, 2021, the assets held in the
Trust Account were held in U.S. Treasury Bills with a maturity of 185 days or less and in
money market funds which invest in U.S. Treasury securities. During the nine months ended September 30, 2021, the Company did not withdraw
any of the interest income from the Trust Account to pay its tax obligations.
The Company classifies its United States Treasury
securities as held-to-maturity in accordance with FASB ASC Topic 320 “Investments - Debt and Equity Securities.” Held-to-maturity
securities are those securities which the Company has the ability and intent to hold until maturity. Held-to-maturity treasury securities
are recorded at amortized cost and adjusted for the amortization or accretion of premiums or discounts.
A decline in the market
value of held-to-maturity securities below cost that is deemed to be other than temporary, results in an impairment that reduces the carrying
costs to such securities’ fair value. The impairment is charged to earnings and a new cost basis for the security is established.
To determine whether an impairment is other than temporary, the Company considers whether it has the ability and intent to hold the investment
until a market price recovery and considers whether evidence indicating the cost of the investment is recoverable outweighs evidence to
the contrary. Evidence considered in this assessment includes the reasons for the impairment, the severity and the duration of the impairment,
changes in value subsequent to year-end, forecasted performance of the investee, and the general market condition in the geographic area
or industry in which the investee operates.
Premiums and discounts are amortized or accreted
over the life of the related held-to-maturity security as an adjustment to yield using the effective-interest method. Such amortization
and accretion are included in the “interest income” line item in the statements of operations. Interest income is recognized
when earned.
The carrying value, excluding gross unrealized
holding loss and fair value of held to maturity securities on September 30, 2021 are as follows:
|
|
Carrying
Value as of
September 30,
2021
|
|
|
Gross
Unrealized
Gains
|
|
|
Gross
Unrealized
Losses
|
|
|
Fair Value
as of
September 30,
2021
|
|
U.S. Treasury Securities
|
|
|
146,634,155
|
|
|
|
-
|
|
|
|
(71
|
)
|
|
|
146,634,084
|
|
|
|
$
|
146,634,155
|
|
|
$
|
-
|
|
|
$
|
(71
|
)
|
|
$
|
146,634,084
|
|
Deferred
Offering Costs
The Company
complies with the requirements of the ASC 340-10-S99-1. Offering costs consisted of legal, accounting, underwriting fees and other
costs incurred through the IPO that were directly related to the Public Offering. Offering costs amounted to $9,998,781 and were
charged to shareholders’ equity upon the completion of the Initial Public Offering.
Net Income (Loss) Per Ordinary Share
The Company has two
classes of shares, which are referred to as Class A ordinary share and Class B ordinary share. Earnings and losses are shared pro
rata between the two classes of shares. The Company has not considered the effect of the
warrants sold in the Initial Public Offering and the Private Placement to purchase an aggregate of 14,437,500 of the Company’s
Class A ordinary shares in the calculation of diluted income per share, since their exercise is contingent upon future
events. As a result, diluted net loss per ordinary share is the same as basic net loss per ordinary share for the periods. Accretion
of the carrying value of Class A ordinary shares to redemption value is excluded from net income per ordinary share because the
redemption value approximates fair value. The table below presents a reconciliation of the numerator and denominator used to compute
basic and diluted net income per share for each class of ordinary share:
|
|
For the three months ended
September 30, 2021
|
|
|
For the nine months ended September 30, 2021
|
|
|
|
Class A
|
|
|
Class B
|
|
|
Class A
|
|
|
Class B
|
|
Basic and diluted net loss per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
Numerator:
|
|
|
|
|
|
|
|
|
|
|
|
|
Allocation of net loss
|
|
$
|
(68,268
|
)
|
|
$
|
(18,893
|
)
|
|
$
|
(52,974
|
)
|
|
$
|
(36,761
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Denominator:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average shares outstanding
|
|
|
12,782,813
|
|
|
|
3,537,704
|
|
|
|
4,307,761
|
|
|
|
2,989,354
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and diluted net loss per share
|
|
$
|
(0.01
|
)
|
|
$
|
(0.01
|
)
|
|
$
|
(0.01
|
)
|
|
$
|
(0.01
|
)
|
Fair
Value of Financial Instruments
The fair
value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 820, “Fair Value
Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheet, primarily due to their short-term
nature.
Ordinary
Shares Subject to Possible Redemption
All
of the 14,375,000 Class A ordinary shares sold as part of the Units in the IPO contain a redemption feature which allows for the
redemption of such public shares in connection with the Company’s liquidation, if there is a stockholder vote or tender offer
in connection with the Business Combination and in connection with certain amendments to the Company’s certificate of
incorporation. In accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480
“Distinguishing Liabilities from Equity” and with the SEC and its staff’s guidance on redeemable equity
instruments, which has been codified in ASC 480-10-S99, redemption provisions not solely within the control of the Company require
ordinary shares subject to redemption to be classified outside of permanent equity.
The
Class A ordinary share is subject to SEC and its staff’s guidance on redeemable equity instruments, which has been codified in
ASC 480-10-S99. If it is probable that the equity instrument will become redeemable, the Company has the option to either accrete changes
in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will
become redeemable, if later) to the earliest redemption date of the instrument or to recognize changes in the redemption value immediately
as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The
Company recognizes changes in redemption value immediately as they occur. Immediately upon the closing of the IPO, the Company recognized
the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable ordinary share resulted
in charges against additional paid-in capital and accumulated deficit.
As
of September 30, 2021, the ordinary share reflected on the balance sheet are reconciled in the following table:
Gross proceeds
from IPO
|
|
$
|
146,625,000
|
|
Less:
|
|
|
|
|
Class
A ordinary share issuance costs
|
|
|
(9,998,781
|
)
|
Plus:
|
|
|
|
|
Accretion
of carrying value to redemption value
|
|
|
9,998,781
|
|
Class
A ordinary shares subject to possible redemption
|
|
$
|
146,625,000
|
|
Income
Taxes
The
Company follows the asset and liability method of accounting for income taxes under FASB ASC 740, “Income Taxes.” Deferred
tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial
statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are
measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to
be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period
that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected
to be realized.
ASC
Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax
positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than
not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the
Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as
income tax expense. As of September 30, 2021 and December 31, 2020, there were no unrecognized tax benefits and no amounts accrued for
interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals
or material deviation from its position. The Company’s management does not expect that the total amount of unrecognized tax benefits
will materially change over the next twelve months.
The
Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently
not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s
tax provision was zero for the periods presented.
Concentration
of Credit Risk
Financial
instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution,
which, at times, may exceed the Federal Depository Insurance Company coverage of $250,000. The Company has not experienced losses on
these accounts and management believes the Company is not exposed to significant risks on such accounts.
Recent
Accounting Pronouncements
In
August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06,
Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s
Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates
the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies
the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard
also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s
own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for
all convertible instruments. ASU 2020-06 is effective January 1, 2022 and should be applied on a full or modified retrospective basis,
with early adoption permitted beginning on January 1, 2021. The Company is currently assessing the impact, if any, that ASU 2020-06 would
have on its financial position, results of operations or cash flows.
Management
does not believe that any other recently issued, but not effective, accounting standards, if currently adopted, would have a material
effect on the Company’s financial statements.
Note
4 — Initial Public Offering
On
July 12, 2021, the Company initially sold 14,375,000 Units, which includes the full exercise by the underwriters of
the over-allotment option to purchase an additional 1,875,000 Units, at a purchase price of $10.00 per Unit. Each
Unit consists of one share of Class A ordinary share, and one-half of one redeemable warrant. Each whole Public
Warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment (See
Note 8).
In connection with the closing of the IPO, the Company issued to Maxim
143,750 Class A ordinary shares (the “representative shares”). Maxim has agreed not to transfer, assign or sell any such
shares until the completion of the Company’s initial Business Combination. In addition, Maxim has agreed (i) to waive its redemption
rights with respect to such shares in connection with the completion of the Company’s initial business combination and (ii) to
waive its rights to liquidating distributions from the trust account with respect to such shares if the Company fails to complete its
initial business combination within 12 months (or up to 21 months if we extend the period of time to consummate a business combination
by the full amount of time) from the closing of the IPO.
Note
5 — Private Placement
Simultaneously
with the closing of the IPO, the Sponsor purchased an aggregate of 7,250,000 Private Placement Warrants at a price of
$1.00 per Private Placement Warrant, for an aggregate purchase price of $7,250,000, in a private placement. A portion of the proceeds
from the private placement was added to the proceeds from the IPO held in the Trust Account.
The
Private Placement Warrants are identical to the Public Warrants, except that the Private Warrants (i) will not be redeemable by the Company
and (ii) will not be transferable, assignable or salable until the completion of the initial Business Combination and (iii) may be exercised
for cash or a cashless basis at the holder’s option (see Note 8).
Note
6 — Related Party Transactions
Founder
Shares
On
January 25, 2021, the Sponsor was issued 5,000,000 Class B ordinary shares, par value $0.0001 per share (the “Founder
Shares”) for $25,000, or approximately $0.005 per share, which proceeds were used to reduce the amount due to a related party.
On April 9, 2021, the sponsor forfeited to the Company for no consideration an aggregate of 1,406,250 Founder Shares, which
the Company cancelled, resulting in a decrease in the total number of Founder Shares outstanding from 5,000,000 shares to 3,593,750 shares,
which included up to 468,750 founder shares subject to forfeiture to the extent that the underwriter’s over-allotment
option was not exercised in full or in part. Due to the underwriters’ exercise of their full over-allotment on July 12, 2021, these 468,750 Founders
Shares are no longer subject to forfeiture.
The
Sponsor, officers and directors have agreed not to transfer, assign or sell any of their Founder Shares until the earliest of (A) one
year after the completion of the initial Business Combination and (B) subsequent to the initial Business Combination, (x) if
the closing price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share
dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least
150 days after the initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, share
exchange or other similar transaction that results in all of the Public Shareholders having the right to exchange their ordinary shares
for cash, securities or other property (the “Lock-up”). Any permitted transferees would be subject to the same restrictions
and other agreements of our Sponsor, officers and directors with respect to any Founder Shares.
Promissory
Note — Related Party
On
January 22, 2021, the Sponsor agreed to loan the Company up to $200,000 to be used for a portion of the expenses of the IPO. This
loan is non-interest bearing and payable after the date of the consummation of the Public Offering. As of September 30, 2021 and December
31, 2020, the Company had borrowed $171,356 and $0, respectively, which is currently due upon demand.
Due
to Related Party
The Sponsor
has paid certain formation costs and deferred offering costs on behalf of the Company which are recorded as due to related party in the
amount $56,266 as of December 31, 2020, and which is due upon demand. On January 25, 2021, the liability was reduced by
$25,000 in exchange for the issuance of Founder Shares to the Sponsor. As of September 30, 2021, there is no amount due to related
party.
Working
Capital Loans
In
addition, in order to finance transaction costs in connection with an intended Business Combination, the Sponsor or an affiliate of the
Sponsor, or certain of the Company’s officers and directors, may, but are not obligated to, loan the Company funds as may be required
(“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans
out of the proceeds of the Trust Account released to it. Otherwise, the Working Capital Loans may be repaid only out of funds held outside
the Trust Account. In the event that the initial Business Combination does not close, the Company may use a portion of the working capital
held outside the Trust Account to repay Working Capital Loans but no proceeds from the Trust Account would be used to repay the Working
Capital Loans. Up to $1,500,000 of the Working Capital Loans may be convertible into warrants of the post Business Combination entity
at a price of $1.00 per warrant at the option of the lender. Such warrants would be identical to the Private Placement Warrants.
Except as set forth above, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist
with respect to such loans. Prior to the completion of the initial Business Combination, the Company does not expect to seek loans from
parties other than the Sponsor, its affiliates or any members of the management team as the Company does not believe third parties will
be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in the Company’s Trust Account.
As of September 30, 2021 and December 31, 2020, the Company had no borrowings under the working capital loans.
Administrative
Support Agreement
Commencing
on the date that the Company’s securities are first listed, the Company agreed to reimburse an affiliate of the Sponsor for office
space, secretarial and administrative services provided to members of the management team, in the amount of $10,000 per month. Upon
completion of the initial Business Combination or the Company’s liquidation, it will cease paying these monthly fees. For the three
and nine months ended September 30, 2021, $27,742 had been paid and charged to operating expenses. There were no amounts paid or charged
for the period from July 31 (inception) through September 30, 2020.
Note
7 — Commitments and Contingencies
Registration
Rights
The
holders of the Founder Shares, Private Placement Warrants, Class A ordinary shares underlying the Private Placement Warrants and
securities that may be issued upon conversion of Working Capital Loans will have registration rights pursuant to a registration rights
agreement to be signed prior to or on the effective date of the Public Offering. The holders of these securities are entitled to make
up to three demands, excluding short form demands, that the Company register such securities under the Securities Act. In addition, the
holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion
of the Company’s initial Business Combination and rights to require the Company to register for resale such securities pursuant
to Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not permit any registration
statement filed under the Securities Act to become effective until termination of the applicable lock-up period. Notwithstanding the
foregoing, the underwriter may not exercise its demand and “piggyback” registration rights after five (5) and seven (7) years after
the effective date of the registration statement for the initial public offering and may not exercise its demand rights on more than
one occasion. The Company will bear the expenses incurred in connection with the filing of any such registration statements.
Underwriting
Agreement
The
underwriter had a 45-day option from the date of the IPO to purchase up to an aggregate of 1,875,000 additional Units at the
public offering price less the underwriting commissions to cover over-allotments, if any. On July 12, 2021, the underwriter fully
exercised its over-allotment option.
The
underwriters are entitled to a deferred underwriting fee of 3.5% of the gross proceeds of the Public Offering, or $5,031,250 in the aggregate.
The deferred fee will be payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company
completes an initial Business Combination, subject to the terms of the underwriting agreement.
Note
8 — Shareholders’ Equity
Preferred
Shares — The Company is authorized to issue 1,000,000 preference shares with a par value of $0.0001 and
with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of
directors. At September 30, 2021 and December 31, 2020, there were no preference shares issued or outstanding.
Class A
Ordinary Shares — The Company is authorized to issue 200,000,000 Class A ordinary shares with
a par value of $0.0001 per share. At September 30, 2021 and December 31, 2020, there were 143,750 and no Class A ordinary shares
issued and shares outstanding, excluding 14,375,000 and no Class A ordinary shares subject to redemption, respectively.
Class B
Ordinary Shares — The Company is authorized to issue 20,000,000 Class B ordinary shares with a par
value of $0.0001 per share. At December 31, 2020, there were no Class B ordinary shares issued or outstanding. On January
25, 2021, the Company issued 5,000,000 Class B ordinary shares to its Sponsor. On April 9, 2021, the Sponsor forfeited
to the Company for no consideration an aggregate of 1,406,250 Class B ordinary shares, which the Company cancelled, resulting
in a decrease in the total number of Class B ordinary shares outstanding from 5,000,000 shares to 3,593,750 shares.
As a result of the underwriters’ election to fully exercise of their over-allotment option on July 12, 2021, the 468,750 shares
were no longer subject to forfeiture. As of September 30, 2021 and December 31, 2020, there were 3,593,750 and no Class B ordinary
shares issued or outstanding, respectively.
Holders
are entitled to one vote for each Class B ordinary share. Holders of the Class A ordinary shares and holders of the Class B
ordinary shares will vote together as a single class on all matters submitted to a vote of the Company’s shareholders, except as
required by law. Unless specified in the Company’s amended and restated memorandum and articles of association, or as required
by applicable provisions of Cayman Islands law or applicable stock exchange rules, the affirmative vote of a majority of the ordinary
shares that are voted is required to approve any such matter voted on by the Company’s shareholders.
The
Class B ordinary shares will automatically convert into Class A ordinary shares at the time of the initial Business Combination
on a one-for-one basis (subject to adjustment for share sub-divisions, share dividends, reorganizations, recapitalizations and the
like). In the case that additional Class A ordinary shares, or equity-linked securities, are issued or deemed issued in excess
of the amounts offered in this prospectus and related to the closing of the initial Business Combination, the ratio at which Class B
ordinary shares shall convert into Class A ordinary shares will be adjusted (unless the holders of a majority of the outstanding
Class B ordinary shares agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number
of Class A ordinary shares issuable upon conversion of all Class B ordinary shares will equal, in the aggregate, on an as-converted basis, 20%
of the sum of the total number of all ordinary shares outstanding upon completion of the Public Offering (not including Class A
ordinary shares issuable to Maxim) plus all Class A ordinary shares and equity-linked securities issued or deemed issued in
connection with the initial Business Combination (excluding any shares or equity-linked securities issued, or to be issued, to any
seller in the initial Business Combination, any private placement-equivalent securities issued to our sponsor or its affiliates
upon conversion of Working Capital loans).
Warrants —
As of September 30, 2021, there were 7,187,500 public warrants and 7,250,000 private placement warrants outstanding. At December 31, 2020,
there were no warrants outstanding. Each whole Public Warrant entitles the holder to purchase one Class A ordinary share at
a price of $11.50 per share, subject to adjustment. The Public Warrants will become exercisable on the later of twelve months from
the closing of the Public Offering and 30 days after the completion of the initial Business Combination. Only a whole warrant may
be exercised at a given time by a warrant holder. No fractional warrants will be issued upon separation of the units and only whole warrants
will trade. The warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation.
The
Company has agreed that as soon as practicable, but in no event later than 30 calendar days after the closing of the initial Business
Combination, it will use commercially reasonable best efforts to file, and within 90 calendar days following the initial Business Combination
to have declared effective, a registration statement with the SEC covering the ordinary shares issuable upon exercise of the warrants,
to maintain a current prospectus relating to those ordinary shares until the warrants expire or are redeemed. If a registration statement
covering the ordinary shares issuable upon exercise of the warrants is not effective within the period specified above following the
consummation of the initial Business Combination, public holders of warrants may, until such time as there is an effective registration
statement and during any period when the Company shall have failed to maintain an effective registration statement, exercise warrants
on a cashless basis pursuant to the exemption provided by Section 3(a)(9) of the Securities Act of 1933, as amended, or the Securities
Act, provided that such exemption is available. If the Company’s ordinary shares are at the time of any exercise of a warrant not
listed on a national securities exchange such that it satisfies the definition of a “covered security” under Section 18(b)(1)
of the Securities Act, the Company may, at its option, require holders of public warrants who exercise their warrants to do so on a “cashless
basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, it will not be required
to file or maintain in effect a registration statement, but will be required to use its best efforts to register or qualify the shares
under applicable blue sky laws to the extent an exemption is not available. If that exemption, or another exemption, is not available,
holders will not be able to exercise their warrants on a cashless basis.
In
no event will the Company be required to net cash settle any warrant. In the event that a registration statement is not effective for
the exercised warrants, the purchaser of a unit containing such warrant will have paid the full purchase price for the unit solely for
the Class A ordinary share underlying such unit.
Redemption
of Warrants for Cash When the Price per Class A Ordinary Share Equals or Exceeds $18.00.
Once
the warrants become exercisable, the Company may call the warrants for redemption (excluding the Private Placement Warrants):
|
●
|
in whole and not in part:
|
|
|
|
|
●
|
at a price of $0.01 per warrant;
|
|
|
|
|
●
|
upon a minimum of 30 days’ prior written notice of redemption to each warrant holder; and
|
|
|
|
|
●
|
if, and only if, the closing price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which notice of the redemption is given to the warrant holders (the “Reference Value”).
|
In
addition, if (x) the Company issues additional ordinary shares or equity-linked securities for capital raising purposes in connection
with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per share (with such
issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any
such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates,
as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances
represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination
on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading
price of the Company’s ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the
Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise
price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued
Price, and the $18.00 per share redemption trigger price described below under “Redemption” will be adjusted (to the nearest
cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price.
The
Private Placement Warrants are identical to the Public Warrants, except that the Private Warrants (i) will not be redeemable by the Company
and (ii) will not be transferable, assignable or salable until the completion of the initial Business Combination and (iii) may be exercised
for cash or a cashless basis at the holder’s option.
NOTE 9. FAIR VALUE MEASUREMENTS
The Company follows the guidance in ASC 820 for
its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets
and liabilities that are re-measured and reported at fair value at least annually.
The fair value of the Company’s financial
assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale
of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the
measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of
observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions
about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities
based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:
|
Level 1:
|
Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.
|
|
Level 2:
|
Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.
|
|
Level 3:
|
Unobservable inputs based on the Company’s assessment of the assumptions that market participants would use in pricing the asset or liability.
|
The following table presents information about
the Company’s assets that are measured at fair value on a recurring basis at September 30, 2021, and indicates the fair value hierarchy
of the valuation inputs the Company utilized to determine such fair value:
Description
|
|
Level
|
|
|
September 30,
2021
|
|
Assets:
|
|
|
|
|
|
|
Marketable securities held in Trust Account
|
|
|
1
|
|
|
$
|
146,634,542
|
|
Note
10 — Subsequent Events
The
Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements
were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure
in the financial statements.